Fractionated (90)y Ibritumomab Tiuxetan (Zevalin (TM)) Radioimmunotherapy As An Initial Therapy of Follicular Lymphoma First Results From a Phase II Study in Patients Requiring Treatment According to GELF/BNLI Criteria

Abstract

Abstract is not available.